by Christine Ann Denny, PhD | Dec 22, 2020 | Uncategorized
Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine. Presented on Tuesday 22nd December 2020 12.30pm EST; 5.30pm UK Chen BK, Luna VM, LaGamma CT, Xu X, Deng SX, Suckow RF, Cooper TB, Shah A,...
by Roger S McIntyre MD | Dec 8, 2020 | Uncategorized
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence Presented on Tuesday 8th December 2020 12.30pm...
by Cristina Cusin, MD | Nov 24, 2020 | Uncategorized
Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review Presented on Tuesday 24th November 2020 12.30pm EST; 5.30pm UK Sakurai H, Jain F, Foster S, Pedrelli P, Mischoulon D, Fava M, Cusin...
by Laurel S. Morris PhD | Nov 10, 2020 | Uncategorized
Ketamine normalizes subgenual cingulate cortex hyper-activity in depression Presented on Tuesday 10th November 2020 12.30pm EST; 5.30pm UK Morris LS, Costi S, Tan A, Stern ER, Charney DS, Murrough JW. Neuropsychopharmacology (2020), 45(6):975-981. PMID: 31896116...
